Antineoplastic used to treat Hodgkin’s disease and other neoplasms. Adverse effects include bone marrow depression, nausea, and vomiting.
A drug that inhibits growth of cancer cells by preventing cell division and is used to treat such cancers as Hodgkin’s disease. It is administered by mouth; common side-effects include loss of appetite, nausea, vomiting, diarrhea, and mouth sores.
An antineoplastic drug used mainly to treat Hodgkin’s disease. It acts by interfering with the process of mitosis, the method by which the cells of the body, including tumours, reproduce themselves.
Primarily utilized in Hodgkin’s disease, this anticancer medication entails side effects commonly associated with such drugs.